EQS-Adhoc: HBM Healthcare Investments achieves value growth of 12.6 percent in the first half of the 2021/2022 financial year
HBM Healthcare Investments' net assets continued to grow in the first half of the 2021/2022?financial year, thanks to the excellent performance of the listed investment in Cathay Biotech?in China and contributions from the private companies portfolio. The net asset value per share?(NAV) increased by 12.6 percent to CHF 335.64 as at 30 September 2021, while the share?price rose by 6 percent.
Based on these key figures, HBM Healthcare Investments expects a net profit of around CHF?270 million for the first half of the financial year. In the same period of the previous year, a net?profit of CHF 441 million was reported.
These figures represent the preliminary result based on the current status of the closing?process. The definitive result will be published with the half-year report on 22 October 2021.
Contact For further information, please contact Dr Andreas Wicki on +41 41 710 75 77, or at firstname.lastname@example.org.End of ad hoc announcement Language: English Company: HBM Healthcare Investments AG Bundesplatz 1 6300 Zug
Switzerland Phone: +41438887171 Fax: +41438887172 E-mail: email@example.com Internet: https://www.hbmhealthcare.com ISIN: CH0012627250 Valor: 1262725 Listed: SIX Swiss Exchange EQS News ID: 1237685 ? End of Announcement EQS Group News Service